ERBB2 and pancreatic neoplasm: ERBB2 knockdown in MIA PaCa-2 and PANC-1 cell lines suppressed, however, miR-488 inhibition enhanced the cancer cell cytological malignant behavior; the effects of miR-488 inhibition on pancreatic cancer cells were significantly reversed by ERBB2 knockdown.